The Pathology Network
PrivateLast Round
Accelerator
Jun 14, 2024
Total Funding Raised
$750,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
The Pathology Network is a healthtech company that operates a digital diagnostic management platform, Spes360, to connect hospitals and doctors in Africa with a global network of specialized laboratories and pathologists.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, InsurTech
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pathology Network Comparables
Compare The Pathology Network with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healthshare Health Solutions | 64% | |
| Lancet Laboratories | 62% | |
| Ampath | 62% | |
The Pathology Network Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 14, 2024 | ||||
| Seed | Jan 1, 2023 | ||||
| Grant | Sep 27, 2022 | ||||
| Seed | Jun 2, 2021 | ||||
| Pre Seed | May 13, 2020 |
The Pathology Network Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Hub Africa | Accelerator |
| Villgro Africa | Seed, Pre Seed |
| Jaza Rift Ventures | Seed |
| Kua Ventures | Seed |
| Investing in Innovation (i3) Africa | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 645% MoM, from 185 to 1.4K.
- Jul 30, 2025
Attended the 2nd National Cancer Summit organized by the National Cancer Institute of Kenya.
The Pathology Network Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about The Pathology Network's valuation, stock price, and market status.